Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
12% of adults had used a GLP-1 prescription drug as of May 2024, and global spending is expected to multiply from $6 billion in 2023 to $105 billion by 2030
Certain sections of this blog may contain forward-looking statements that are based on our reasonable expectations, estimates, projections and assumptions
Villani LA, et al
Box 1: Recent Trump Administration Obesity Drug Initiatives In November 2025, the Trump administration announced reaching a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1s for Medicare, Medicaid, and those purchasing the drugs directly from the manufacturers through a new TrumpRx website
With the development of various industries, higher discharge and faster-charging requirements for batteries have pushed the technical improvement and application of rate batteries
Hematopoietic cell- versus enterocyte-derived dipeptidyl peptidase-4 differentially regulates triglyceride excursion in mice
US$ 25.69
US$ 24.01
US$ 28.19
US$ 23.23
US$ 29.15
